Want to see DNLI full AI Analyst Report?
Denali Therapeutics (DNLI) Hedge Fund Trading Activity
892 Followers
Trend: ▲ Hedge Funds Increased Holdings by 987.6K Shares Last Quarter
Hedge Fund Holdings in DNLI
Based on the 13F filings of 489 Hedge Funds tracked by TipRanks, as submitted to the SEC.
Hedge Fund Confidence Signal
Hedge Fund Activity
Activity
Star Ranking
| Follow | |||||||
|---|---|---|---|---|---|---|---|
 Kenneth Tropin | Graham Capital Management, L.P. | New | 100.00% | $403,007 | <0.01% | ||
 BlackRock, Inc. | Added | 7.61% | $360,759,342 | <0.01% | |||
| Felix Baker | Baker Bros Advisors LP | Added | 0.07% | $96,047,122 | 0.48% | ||
| Michael Rockefeller | Woodline Partners LP | Not Changed | 0.00% | $9,364,189 | 0.03% | ||
 Antony J. Abbiati | SCS Capital Management LLC | Not Changed | 0.00% | $5,092,509 | 0.05% | ||
 Ken Fisher | Fisher Asset Management LLC | Reduced | -0.93% | $62,092,247 | 0.02% |
FAQ
Which hedge funds hold Denali Therapeutics?
The hedge funds that hold the most shares in Denali Therapeutics are Antony J. Abbiati, BlackRock, Inc. and Kenneth Tropin.
Are hedge funds buying or selling DNLI?
In the last quarter hedge funds have Increased their holdings in Denali Therapeutics by 987.6K shares.
Where can I see a list of the best rated hedge funds?
You can see a list of the best hedge funds here.
Who is the best-performing hedge fund manager?
The top-rated hedge fund managers can be seen here: Top Hedge Fund Managers
Does Warren Buffet hold shares in Denali Therapeutics stock?
Warren Buffet currently does not own shares in Denali Therapeutics.
What is a 13F filing, and how does it help investors?
A 13F form, also known as a "Report of Investment Manager," is a quarterly report that investment advisors registered with the Securities and Exchange Commission (SEC) must file if they manage at least $100 million in assets. The 13F form lists all of the publicly traded securities that the investment advisor owns as of the end of the reporting period. To read more about the 13F, click here
